UNSPSC 51283510: Dicloxacillin sodium anhydrous

This classification denotes a penicillin antibiotic with the molecular formula C19H16Cl2N3O5S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4CKS6MOL6Z, chemically known as monosodium (2s,5r,6r)-6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate, but more generally known as dicloxacillin sodium anhydrous, which bears US NIH Compound Identifier 64688.

European Medicines Agency schedules dicloxacillin sodium anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07099MIG. Most nations, for tariff purposes, schedule dicloxacillin sodium anhydrous under HS 29411090. SMILES: CC1C(C(NO1)C2C(CCCC2CL)CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].[NA+].

UNSPSC 51283510 Dicloxacillin sodium anhydrous is a Commodity code that sits at the lowest tier of the taxonomy but shows minimal alignment with actual state and local procurement activity. The recent opportunities posted under this code involve naloxone systems, medical and first aid supplies for emergency responders, and generic pharmaceutical procurement through cooperative purchasing vehicles—none of which specifically targets dicloxacillin sodium anhydrous or narrow-spectrum beta-lactam antibiotics. State and local bodies are using this code to solicit broader pharmaceutical categories, emergency medical supplies, and multi-source generic drug programs rather than specific antibiotic formulations. The issuing bodies span county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health commissions (Texas HHS), and multi-state cooperative purchasing alliances (MMCAP through Minnesota Department of Administration).

Recent activity appears concentrated in Florida and Minnesota, with Texas and Oregon engaged through state-level and cooperative procurement mechanisms. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) sought naloxone and drug deactivation systems with no direct antibiotic component. The City of Tampa's ITB for medical and first aid supplies (26P00145, due March 13, 2026) targeted emergency response consumables for the Fire Department Rescue Division under a certified Small Local Business Enterprise set-aside with an estimated contract value of $700,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP (S1070000015802, due March 26, 2026) established multi-state generic pharmaceutical contracts through three authorized wholesalers with a two-year initial term. The Texas Health and Human Services Commission's RFI (HHS0017013, posted April 3, 2026) explored direct-to-manufacturer prescription programs. The code shows limited relevance to dicloxacillin procurement specifically; vendors pursuing antibiotic-category opportunities should monitor pharmaceutical RFPs under broader generic-drug and multi-source commodity codes rather than rely on this narrow formulation code.